To explore differences in polygenicity to PD risk among LRRK2 G2019S carriers and non-carriers, we compared the distributions adjusted for age, sex and ancestry PCs of the modified PRS between individuals with and without PD. This evidence concerns the gene LRRK2 and Parkinson disease.